Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuefei Tan

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Amide-based inhibitors of p38alpha MAP kinase. Part 2: design, synthesis and SAR of potent N-pyrimidyl amidesRichland Tester, Xuefei Tan, Gregory R Luedtke, et al.
Bioengineered|March 7, 2020
Advanced in developmental organic and inorganic nanomaterial: a reviewKhalisanni Khalid, Xuefei Tan, Hayyiratul Fatimah Mohd Zaid, et al.
Bioorganic & Medicinal Chemistry|December 27, 2015
Highly potent tyrosinase inhibitor, neorauflavane from Campylotropis hirtella and inhibitory mechanism with molecular dockingXuefei Tan, Yeong Hun Song, Chanin Park, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
Discovery of Potent and Efficacious Influenza PB2 InhibitorsJun Wu, Yongfu Liu, Dongbo Li, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Piperidine-based heterocyclic oxalyl amides as potent p38 alpha MAP kinase inhibitorsBabu J Mavunkel, John J Perumattam, Xuefei Tan, et al.
Journal of Medicinal Chemistry|September 26, 2015
Discovery of 4-Aryl-5,6,7,8-tetrahydroisoquinolines as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors: In Vivo Evaluation in Rodents and Cynomolgus MonkeysRainer E Martin, Johannes D Aebi, Benoit Hornsperger, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2010
Design and synthesis of piperazine-indole p38 alpha MAP kinase inhibitors with improved pharmacokinetic profilesXuefei Tan, Richland W Tester, Gregory R Luedtke, et al.
Journal of Medicinal Chemistry|August 16, 2022
Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus InfectionDongdong Chen, Xuefei Tan, Wenming Chen, et al.
Journal of Medicinal Chemistry|June 13, 2020
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) InhibitorsYongfu Liu, Jun Wu, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|April 8, 2025
Discovery of Naphthyridinone Derivatives as Selective and Potent PKMYT1 Inhibitors with Antitumor EfficacyBo Chen, Xiaofeng Liu, Tong Mu, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Amide-based inhibitors of p38alpha MAP kinase. Part 2: design, synthesis and SAR of potent N-pyrimidyl amidesRichland Tester, Xuefei Tan, Gregory R Luedtke, et al.
Bioengineered|March 7, 2020
Advanced in developmental organic and inorganic nanomaterial: a reviewKhalisanni Khalid, Xuefei Tan, Hayyiratul Fatimah Mohd Zaid, et al.
Bioorganic & Medicinal Chemistry|December 27, 2015
Highly potent tyrosinase inhibitor, neorauflavane from Campylotropis hirtella and inhibitory mechanism with molecular dockingXuefei Tan, Yeong Hun Song, Chanin Park, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
Discovery of Potent and Efficacious Influenza PB2 InhibitorsJun Wu, Yongfu Liu, Dongbo Li, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Piperidine-based heterocyclic oxalyl amides as potent p38 alpha MAP kinase inhibitorsBabu J Mavunkel, John J Perumattam, Xuefei Tan, et al.
Journal of Medicinal Chemistry|September 26, 2015
Discovery of 4-Aryl-5,6,7,8-tetrahydroisoquinolines as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors: In Vivo Evaluation in Rodents and Cynomolgus MonkeysRainer E Martin, Johannes D Aebi, Benoit Hornsperger, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2010
Design and synthesis of piperazine-indole p38 alpha MAP kinase inhibitors with improved pharmacokinetic profilesXuefei Tan, Richland W Tester, Gregory R Luedtke, et al.
Journal of Medicinal Chemistry|August 16, 2022
Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus InfectionDongdong Chen, Xuefei Tan, Wenming Chen, et al.
Journal of Medicinal Chemistry|June 13, 2020
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) InhibitorsYongfu Liu, Jun Wu, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|April 8, 2025
Discovery of Naphthyridinone Derivatives as Selective and Potent PKMYT1 Inhibitors with Antitumor EfficacyBo Chen, Xiaofeng Liu, Tong Mu, et al.
Pageof 4